Meanwhile, it can also suppress the glycolic process by restoring the abnormal expression of MCT1/4, CD147, and HIF‐1α in GPL, which provides a new therapeutic strategy for the prevention of gastric cancer [49]. The gene discussed is IL31RA; the disease is gastric cancer.